Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells

TM Filtz, W Guan, RP Artymyshyn, M Facheco, C Ford and PB Molinoff

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia.

Mechanisms underlying agonist- and antagonist-induced up-regulation in HEK-293 cells transfected to express D2 dopamine receptors were investigated. We have reported previously that exposure of cells to agonists and antagonists led to an increase in the density of receptors. The time course of up-regulation on exposure to (-)- sulpiride, a D2 dopamine-selective antagonist, was measured. A lag in the effect of antagonists not seen with up-regulation induced by exposure to agonists was observed. Effects of N-propylnorapomorphine were synergistic with those of cyclic AMP analogs, however, synergistic effects between (-)-sulpiride and cyclic AMP analogs were not observed. These findings suggest that separate mechanisms may be involved in agonist- and antagonist-induced up-regulation. Changes in mRNA levels did not appear to account for the increase in receptors after agonist or antagonist treatment. Results of experiments with cycloheximide, a protein-synthesis inhibitor, suggest that increased protein synthesis, and not decreased protein degradation, is responsible for up-regulation by both NPA and (-)-sulpiride. Studies monitoring receptor recovery after treatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible alkylating agent, suggest that rates of receptor incorporation into membranes are increased after treatment with either an agonist or an antagonist.

Volume 271, Issue 3, pp. 1574-1582, 12/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				P.-A. Vidi, B. R. Chemel, C.-D. Hu, and V. J. Watts Ligand-Dependent Oligomerization of Dopamine D2 and Adenosine A2A Receptors in Living Neuronal Cells Mol. Pharmacol., September 1, 2008; 74(3): 544 - 551. [Abstract] [Full Text] [PDF]

				L. Thielemans, I. Depoortere, J. Perret, P. Robberecht, Y. Liu, T. Thijs, C. Carreras, E. Burgeon, and T. L. Peeters Desensitization of the Human Motilin Receptor by Motilides J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1397 - 1405. [Abstract] [Full Text] [PDF]

				K. Van Craenenbroeck, S. D. Clark, M. J. Cox, J. N. Oak, F. Liu, and H. H. M. Van Tol Folding Efficiency Is Rate-limiting in Dopamine D4 Receptor Biogenesis J. Biol. Chem., May 13, 2005; 280(19): 19350 - 19357. [Abstract] [Full Text] [PDF]

				K. D. Burris, T. F. Molski, C. Xu, E. Ryan, K. Tottori, T. Kikuchi, F. D. Yocca, and P. B. Molinoff Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 381 - 389. [Abstract] [Full Text] [PDF]

				J. Viyoch, S. Ohdo, E. Yukawa, and S. Higuchi Dosing Time-Dependent Tolerance of Catalepsy by Repetitive Administration of Haloperidol in Mice J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 964 - 969. [Abstract] [Full Text]

				P. A. Zaki, D. E. Keith Jr., J. B. Thomas, F. I. Carroll, and C. J. Evans Agonist-, Antagonist-, and Inverse Agonist-Regulated Trafficking of the delta -Opioid Receptor Correlates with, but Does Not Require, G Protein Activation J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1015 - 1020. [Abstract] [Full Text]

				N. Hukovic, M. Rocheville, U. Kumar, R. Sasi, S. Khare, and Y. C. Patel Agonist-dependent Up-regulation of Human Somatostatin Receptor Type 1 Requires Molecular Signals in the Cytoplasmic C-tail J. Biol. Chem., August 27, 1999; 274(35): 24550 - 24558. [Abstract] [Full Text] [PDF]

				G. Davidkova, L.-W. Zhou, M. Morabito, S.-P. Zhang, and B. Weiss D2 Dopamine Antisense RNA Expression Vector, Unlike Haloperidol, Produces Long-term Inhibition of D2 Dopamine-Mediated Behaviors without Causing Up-regulation of D2 Dopamine Receptors J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1187 - 1196. [Abstract] [Full Text]

				B. A. McCool, J.-P. Pin, M. M. Harpold, P. F. Brust, K. A. Stauderman, and D. M. Lovinger Rat group I Metabotropic Glutamate Receptors Inhibit Neuronal Ca2+ Channels via Multiple Signal Transduction Pathways in HEK 293 Cells J Neurophysiol, January 1, 1998; 79(1): 379 - 391. [Abstract] [Full Text] [PDF]

				M. Gopalakrishnan, E. J. Molinari, and J. P. Sullivan Regulation of Human alpha 4beta 2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger Pathways Mol. Pharmacol., September 1, 1997; 52(3): 524 - 534. [Abstract] [Full Text]

				D. S. Cowen, P. B. Molinoff, and D. R. Manning 5-Hydroxytryptamine1A Receptor-Mediated Increases in Receptor Expression and Activation of Nuclear Factor-kappa B in Transfected Chinese Hamster Ovary Cells Mol. Pharmacol., August 1, 1997; 52(2): 221 - 226. [Abstract] [Full Text]